1. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
- Author
-
Cho, Dae Hyeon, Kim, Si-Ho, Jeon, Cheon Hoo, Kim, Hyoung Tae, Park, Kyoung-Jin, Kim, Junyoung, Kwak, Jiyeong, Kwan, Byung Soo, Kong, Sungmin, Lee, Jung Won, Kim, Kwang Min, and Wi, Yu Mi
- Subjects
CLOSTRIDIOIDES difficile ,LEUKOCYTE count ,TREATMENT effectiveness ,ENZYME-linked immunosorbent assay - Abstract
Purpose: The clinical significance of negative toxin enzyme immunoassays (EIA) for Clostridioides difficile infections (CDIs) is unclear. Our study aimed to investigate the significance of toxin EIA-negative in the diagnosis and prognosis of CDI. Methods: All stool specimens submitted for C. difficile toxin EIA testing were cultured to isolate C. difficile. In-house PCR for tcdA, tcdB, cdtA, and cdtB genes were performed using C. difficile isolates. Stool specimens were tested with C. difficile toxins A and B using EIA kit (RIDASCREEN Clostridium difficile toxin A/B, R-Biopharm AG, Darmstadt, Germany). Characteristics and subsequent CDI episodes of toxin EIA-negative and -positive patients were compared. Results: Among 190 C. difficile PCR-positive patients, 83 (43.7%) were toxin EIA-negative. Multivariate analysis revealed independent associations toxin EIA-negative results and shorter hospital stays (OR = 0.98, 95% CI 0.96–0.99, p = 0.013) and less high-risk antibiotic exposure in the preceding month (OR = 0.38, 95% CI 0.16–0.94, p = 0.035). Toxin EIA-negative patients displayed a significantly lower white blood cell count rate (11.0 vs. 35.4%, p < 0.001). Among the 54 patients who were toxin EIA-negative and did not receive CDI treatment, three (5.6%) were diagnosed with CDI after 7–21 days without complication. Conclusion: Our study demonstrates that toxin EIA-negative patients had milder laboratory findings and no complications, despite not receiving treatment. Prolonged hospitalisation and exposure to high-risk antibiotics could potentially serve as markers for the development of toxin EIA-positive CDI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF